FDA Approves BioMedical Enterprises’ Upgrade to HammerLock Intramedullary Fixation System

BioMedical Enterprises has received clearance from the U.S. Food and Drug Administration on an upgrade to its patent-pending Hammerlock Intramedullary Fixation System for hammertoe deformities, according to a news release.

Advertisement

Upgrades to the HammerLock include a linear body that allows for easier bone fusion, better flexibility in positioning the device and easier insertion.

The system uses the metal Nitinol, an alloy of nickel and titanium, for its shape memory properties. It does not use any wires.

More Articles on FDA Regulations:

FDA Recalls Spacelabs Healthcare’s Anesthesia Workstations
FDA Orders 23andMe to Stop Sale of Personal Genome Service
OrthAlign Receives 510(k) FDA Clearance for ORTHALIGN PLUS System

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.